TriSalus Life Sciences, Inc. (TLSI)

TriSalus Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	22.69	8.53	11.78	9.41	30.3	4.49
Cash & Short-Term Investments	22.69	8.53	11.78	9.41	30.3	4.49
Cash Growth	100.98%	-27.61%	25.10%	-68.93%	575.16%	-
Receivables	5	5.09	3.55	1.56	1.36	0.62
Inventory	3.28	4.05	2.55	1.47	1.29	0.57
Prepaid Expenses	2.37	3.01	2.99	4.77	2.18	-
Other Current Assets	-	-	-	-	-	0.41
Total Current Assets	33.33	20.67	20.86	17.21	35.13	6.08
Property, Plant & Equipment	2.72	2.88	3.27	3.61	1.8	1.26
Other Intangible Assets	-	-	-	0.8	0.79	0.74
Other Long-Term Assets	0.42	0.42	0.47	0.37	0.12	0.05
Total Assets	36.46	23.97	24.6	22	37.84	8.13
Accounts Payable	3.78	2.27	3.39	4.95	1.3	0.61
Accrued Expenses	6.77	7.32	10.53	6.38	4.97	6.73
Current Portion of Long-Term Debt	-	-	-	-	-	42.18
Current Portion of Leases	0.13	0.22	0.35	0.37	-	-
Current Income Taxes Payable	-	0.03	0.03	-	-	-
Other Current Liabilities	0.22	0.38	0.39	20.66	0.1	5.22
Total Current Liabilities	10.91	10.23	14.69	32.36	6.37	54.75
Long-Term Debt	32.76	22.08	-	-	-	-
Long-Term Leases	1.23	1.33	1.24	1.59	-	-
Other Long-Term Liabilities	18.28	16.22	35.73	0.37	0.56	3.54
Total Liabilities	63.19	49.87	51.66	34.32	6.93	58.29
Common Stock	0	0	0	-	0.01	0.01
Additional Paid-In Capital	294.24	253.65	222.44	10.03	6.73	1.36
Retained Earnings	-320.97	-279.55	-249.5	-186.36	-136.34	-107.5
Total Common Equity	-26.73	-25.89	-27.07	-176.33	-129.6	-106.13
Shareholders' Equity	-26.73	-25.89	-27.07	-12.32	30.9	-50.16
Total Liabilities & Equity	36.46	23.97	24.6	22	37.84	8.13
Total Debt	34.12	23.63	1.6	1.96	-	42.18
Net Cash (Debt)	-11.44	-15.1	10.18	7.45	30.3	-37.7
Net Cash Growth	-	-	36.65%	-75.41%	-	-
Net Cash Per Share	-0.35	-0.60	1.08	24.07	3.42	-4.91
Filing Date Shares Outstanding	49.96	32.27	26.76	14.08	12.96	7.67
Total Common Shares Outstanding	49.89	31.28	26.41	14.08	10.72	7.67
Working Capital	22.42	10.44	6.18	-15.14	28.76	-48.67
Book Value Per Share	-0.54	-0.83	-1.02	-12.53	-12.09	-13.83
Tangible Book Value	-26.73	-25.89	-27.07	-177.13	-130.4	-106.87
Tangible Book Value Per Share	-0.54	-0.83	-1.02	-12.58	-12.16	-13.93
Machinery	-	4.34	3.8	3.87	3.15	2.36
Construction In Progress	-	0.33	0.6	-	-	-
Leasehold Improvements	-	0.77	0.77	0.77	0.78	0.68

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q